BONE DENSITY CHARACTERISTICS IN GOUT PATIENTS WITH COMPLICATIONS OF CHRONIC KIDNEY DISEASE TREATMENT AT THAI NGUYEN CENTRAL HOSPITAL

Thị Thiệp Ngô, Thị Bình Lưu

Main Article Content

Abstract

Objective: Describe the characteristics of bone density and some factors related to bone density in gout patients with complications of chronic kidney disease treated at Thai Nguyen Central Hospital. Research subjects and methods: Cross-sectional descriptive study was conducted on 62 gout patients with complications of chronic kidney disease treated at Thai Nguyen Central Hospital. Results: Mean age 70.89 ±10.37. Chronic kidney disease stage: Stage I accounts for 8.1%, Stage II: 45.2%, Stage IIIa: 25.8%, IIIb: 21.0%, estimated MLCT <60 ml/min/ 1.73 m2 skin accounts for 46.8%. The rate of normal bone density is 16.1%, osteopenia is 38.7%, osteoporosis is 45.2%. Average bone density at the lumbar spine -1.99±1.03, average bone density at the femoral neck -1.08±0.91. There is statistical significance between bone density and time to detect gout, appearance of tophi, and treatment compliance (p<0.05). There was no statistical significance between bone density and HGB concentration, total serum calcium, blood uric acid, proteinuria, and erythrocyteuria in the study subjects (p>0.05). Conclusion: The rate of osteoporosis in gout patients with complications of chronic kidney disease is high, the rate of osteoporosis is 45.2%. Average bone density at the lumbar spine -1.99±1.03, at the femoral neck -1.08±0.91, there is a relationship between bone density and time to detect gout, appearing tophi, treatment compliance (p<0.05).

Article Details

References

Đàm Thị Thanh Tâm, Dương Đình Toàn (2022), "Khảo sát mật độ xương ở những người trên 40 tuổi dựa trên chỉ số T-Score", Tạp chí y học cộng đồng. 4(63).
2. Nguyễn Thị Hương Giang (2013), "Khảo sát mật độ xương và các yếu tố liên quan ở bệnh nhân nam mắc bệnh gút mạn tính", Luận văn thạc sỹ y học, Trường Đại Học y Hà Nội.
3. nephrology International society of (2012), "KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease", Kidney International Supplements.
4. Organization World Health (1994), "Assessment of fracture risk and its application to screening for postmenopausal osteoporosis", Technical Report series 843.
5. Matikainen N, Pekkarinen T, Ryhanen E. M,et al. (2021), "Physiology of Calcium Homeostasis: An Overview", Endocrinol Metab Clin North Am. 50(4), pp. 575-590.
6. Chen L, Peng Y, Fang F,et al. (2015), "Correlation of serum uric acid with bone mineral density and fragility fracture in patients with primary osteoporosis: a single-center retrospective study of 253 cases", Int J Clin Exp Med. 8(4), pp. 6291-6294.
7. Lin X, Zhao C, Qin A,et al. (2015), "Association between serum uric acid and bone health in general population: a large and multicentre study", Oncotarget. 6(34), pp. 35395-35403.
8. Te Kampe R, Janssen M, van Durme C,et al. (2021), "Sex Differences in the Clinical Profile Among Patients With Gout: Cross-sectional Analyses of an Observational Study", J Rheumatol. 48(2), pp. 286-292.